Search

Your search keyword '"Necrolytic Migratory Erythema pathology"' showing total 2 results
Start Over Descriptor "Necrolytic Migratory Erythema pathology" Topic drug eruptions
2 results on '"Necrolytic Migratory Erythema pathology"'

1. Necrolytic Migratory Erythema-like Skin Lesion During Gefitinib Treatment: A Rare Cutaneous Adverse Reaction.

Author

Seong JY, Kong SH, Choi YS, and Suh HS

Subjects
Biopsy, Needle, Carcinoma, Non-Small-Cell Lung diagnosis, Carcinoma, Non-Small-Cell Lung drug therapy, Drug Eruptions etiology, Follow-Up Studies, Gefitinib, Humans, Immunohistochemistry, Lung Neoplasms diagnosis, Lung Neoplasms drug therapy, Male, Middle Aged, Protein Kinase Inhibitors therapeutic use, Quinazolines therapeutic use, Rare Diseases, Risk Assessment, Withholding Treatment, Drug Eruptions pathology, Necrolytic Migratory Erythema chemically induced, Necrolytic Migratory Erythema pathology, Protein Kinase Inhibitors adverse effects, Quinazolines adverse effects
Published
2016
Full Text
View/download PDF

2. Necrolytic migratory erythema in a patient with neuroendocrine carcinoma.

Author

Gronau M, Jäger D, Enk AH, and Hassel JC

Subjects
Adult, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Needle, Capecitabine, Carcinoma, Neuroendocrine drug therapy, Dacarbazine analogs & derivatives, Dacarbazine therapeutic use, Deoxycytidine analogs & derivatives, Deoxycytidine therapeutic use, Diagnosis, Differential, Drug Eruptions pathology, Female, Fluorouracil analogs & derivatives, Fluorouracil therapeutic use, Follow-Up Studies, Humans, Immunohistochemistry, Necrolytic Migratory Erythema pathology, Neoplasm Staging, Pancreatic Neoplasms drug therapy, Paraneoplastic Syndromes pathology, Risk Assessment, Temozolomide, Treatment Outcome, Carcinoma, Neuroendocrine diagnosis, Drug Eruptions diagnosis, Necrolytic Migratory Erythema diagnosis, Pancreatic Neoplasms diagnosis, Paraneoplastic Syndromes diagnosis
Abstract

Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results